Logan Capital Management’s Quest Diagnostics DGX Stock Holding History

Logan Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$953	–	313
2025 Q3	$953	Hold	5	–	–	﹤0.01%	433
2025 Q2	$898	Sell	5 -4	-44%	-$695	﹤0.01%	432
2025 Q1	$1.52K	Buy	9 +1	+13%	+$164	﹤0.01%	494
2024 Q4	$1.21K	Hold	8	–	–	﹤0.01%	475
2024 Q3	$1.24K	Hold	8	–	–	﹤0.01%	454
2024 Q2	$1.09K	Buy	+8	New	+$1.1K	﹤0.01%	443
2021 Q4	–	Sell	-600	Closed	-$87K	–	547
2021 Q3	$87K	Hold	600	–	–	﹤0.01%	327
2021 Q2	$79K	Hold	600	–	–	﹤0.01%	327
2021 Q1	$77K	Buy	+600	New	+$73.9K	﹤0.01%	321
2016 Q2	–	Sell	-3,600	Closed	-$257K	–	269
2016 Q1	$257K	Hold	3,600	–	–	0.02%	272
2015 Q4	$256K	Hold	3,600	–	–	0.02%	266
2015 Q3	$221K	Hold	3,600	–	–	0.02%	272
2015 Q2	$261K	Hold	3,600	–	–	0.02%	281
2015 Q1	$277K	Hold	3,600	–	–	0.02%	252
2014 Q4	$241K	Hold	3,600	–	–	0.02%	262
2014 Q3	$218K	Hold	3,600	–	–	0.02%	258
2014 Q2	$211K	Hold	3,600	–	–	0.01%	261
2014 Q1	$209K	Buy	+3,600	New	+$193K	0.02%	259
2013 Q4	–	Sell	-3,600	Closed	-$222K	–	274
2013 Q3	$222K	Hold	3,600	–	–	0.02%	252
2013 Q2	$216K	Buy	+3,600	New	+$214K	0.02%	241

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Logan Capital Management's DGX Position: Q4 2025 in Review

Logan Capital Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 5 shares — an estimated $953 sold.

Logan Capital Management first reported a position in DGX in Q2 2013 and held it in 20 quarters. The position peaked at $277K in Q1 2015. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

Logan Capital Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
Logan Capital Management sold 5 Quest Diagnostics shares in Q4 2025, an estimated $953.
Logan Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 20 quarters.
Logan Capital Management's Quest Diagnostics position peaked at $277K in Q1 2015.
1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Logan Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.